X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
chemistry (25) 25
human necessities (25) 25
hygiene (25) 25
medical or veterinary science (25) 25
metallurgy (25) 25
organic chemistry (25) 25
peptides (25) 25
preparations for medical, dental, or toilet purposes (25) 25
general tagging of cross-sectional technologies spanning over several sections of the ipc (23) 23
general tagging of new technological developments (23) 23
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (23) 23
technologies for adaptation to climate change (23) 23
technologies or applications for mitigation or adaptation againstclimate change (23) 23
animals (5) 5
index medicus (5) 5
mice (5) 5
inflammation (4) 4
specific therapeutic activity of chemical compounds ormedicinal preparations (4) 4
blt1 (3) 3
chemokines (3) 3
colon cancer (3) 3
host response (3) 3
inflammation and cancer (3) 3
leukotriene b4 (3) 3
male (3) 3
microbiota (3) 3
myd88 (3) 3
receptors, leukotriene b4 - physiology (3) 3
atherosclerosis (2) 2
binding sites (2) 2
chemistry, medicinal (2) 2
chemistry, organic (2) 2
crystallography (2) 2
crystallography, x-ray (2) 2
growth (2) 2
humans (2) 2
leukotriene b4 - physiology (2) 2
matriptase (2) 2
mice, inbred c57bl (2) 2
mice, knockout (2) 2
molecular docking (2) 2
monocyte/macrophages (2) 2
receptors, leukotriene b4 - deficiency (2) 2
receptors, leukotriene b4 - genetics (2) 2
serine endopeptidases - chemistry (2) 2
serine proteinase inhibitors - chemistry (2) 2
structure-activity relationship (2) 2
targeted disruption (2) 2
abridged index medicus (1) 1
administration, oral (1) 1
akkermansia-muciniphila (1) 1
amides (1) 1
amides - chemical synthesis (1) 1
amides - chemistry (1) 1
amides - pharmacokinetics (1) 1
amidine (1) 1
amino acid sequence (1) 1
anti-tumor (1) 1
antibodies and mediators of immunity (1) 1
antibodies, monoclonal - therapeutic use (1) 1
antimicrobial peptides (1) 1
antineoplastic agents - chemistry (1) 1
antineoplastic agents - pharmacology (1) 1
antitumor immunity (1) 1
apolipoprotein-e (1) 1
apolipoproteins e - deficiency (1) 1
apolipoproteins e - physiology (1) 1
arteriosclerosis - etiology (1) 1
arteriosclerosis - genetics (1) 1
b-4 receptor (1) 1
bacteria - isolation & purification (1) 1
bacterial infections - pathology (1) 1
benzamides - chemistry (1) 1
benzamides - pharmacology (1) 1
benzene (1) 1
benzene - chemistry (1) 1
benzene - pharmacology (1) 1
beta-glucans - administration & dosage (1) 1
beta-glucans - therapeutic use (1) 1
biochemistry & molecular biology (1) 1
cancer (1) 1
cancer cells (1) 1
catalytic domain (1) 1
cell line, tumor (1) 1
cell proliferation - drug effects (1) 1
cells, cultured (1) 1
chemokine cxcl2 (1) 1
chemokines - analysis (1) 1
chemotaxis (1) 1
chemotaxis - physiology (1) 1
chemotaxis, leukocyte (1) 1
chemotaxis, leukocyte - genetics (1) 1
chemotaxis, leukocyte - immunology (1) 1
chronic inflammation (1) 1
colony-stimulating factor (1) 1
colorectal-cancer (1) 1
complement c3a - physiology (1) 1
complement c5a - physiology (1) 1
crosses, genetic (1) 1
cyclohexanes - chemical synthesis (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (37) 37
French (6) 6
Chinese (2) 2
German (2) 2
Russian (2) 2
Spanish (2) 2
Japanese (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Molecular cancer therapeutics, ISSN 1535-7163, 06/2019, Volume 18, Issue 6, pp. 1081 - 1091
Pioneering success of antibodies targeting immune checkpoints such as PD-1 and CTLA4 has opened novel avenues for cancer immunotherapy. Along with impressive... 
Journal Article
OncoImmunology, ISSN 2162-4011, 12/2017, Volume 6, Issue 12, pp. e1361593 - e1361593
Inflammation and infection are key promoters of colon cancer but the molecular interplay between these events is largely unknown. Mice deficient in leukotriene... 
host response | microbiota | Colon cancer | inflammation | inflammation and cancer | BLT1 | chemokines | MyD88 | leukotriene B4
Journal Article
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, ISSN 1079-5642, 02/2004, Volume 24, Issue 2, pp. 369 - 375
Objective-Leukotriene B-4 (LTB4), a potent leukocyte chemoattractant, is known to promote several inflammatory diseases, including atherosclerosis. We sought... 
atherosclerosis | PROTECTS MICE | COLONY-STIMULATING FACTOR | CHEMOTAXIS | monocyte/macrophages | MACROPHAGES | leukotriene B-4 receptors | APOLIPOPROTEIN-E | TARGETED DISRUPTION | INFLAMMATION | PERIPHERAL VASCULAR DISEASE | LESION DEVELOPMENT | HEMATOLOGY | E-DEFICIENT MICE | EXPRESSION
Journal Article
Bioorganic & Medicinal Chemistry, ISSN 0968-0896, 06/2014, Volume 22, Issue 12, pp. 3187 - 3203
Journal Article
ONCOIMMUNOLOGY, ISSN 2162-402X, 2017, Volume 6, Issue 12, p. e1361593
Inflammation and infection are key promoters of colon cancer but the molecular interplay between these events is largely unknown. Mice deficient in leukotriene... 
microbiota | AKKERMANSIA-MUCINIPHILA | INTESTINAL TUMORIGENESIS | ANTIMICROBIAL PEPTIDES | IMMUNOLOGY | chemokines | MyD88 | leukotriene B4 | host response | STREPTOCOCCUS-BOVIS BACTEREMIA | TARGETED DISRUPTION | Colon cancer | ONCOLOGY | inflammation | inflammation and cancer | COLORECTAL-CANCER | BLT1 | ANTITUMOR IMMUNITY | CHRONIC INFLAMMATION | B-4 RECEPTOR | INNATE IMMUNITY
Journal Article
OncoImmunology, 12/2017, Volume 6, Issue 12
Inflammation and infection are key promoters of colon cancer but the molecular interplay between these events is largely unknown. Mice deficient in leukotriene... 
microbiota | host response | Colon cancer | inflammation | inflammation and cancer | BLT1 | chemokines | MyD88 | leukotriene B4
Journal Article
Journal of Immunology, ISSN 0022-1767, 06/2005, Volume 174, Issue 11, pp. 7050 - 7056
Intravenous and orally administered beta -glucans promote tumor regression and survival by priming granulocyte and macrophage C receptor 3 (CR3, iC3bR and... 
Journal Article
10/2017
The present invention provides immunosuppression compounds to inhibit the programmed cell death 1 (PD1) signalling pathway. The present invention further... 
METALLURGY | PEPTIDES | HYGIENE | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | ORGANIC CHEMISTRY | CHEMISTRY | MEDICAL OR VETERINARY SCIENCE | HUMAN NECESSITIES
Patent
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.